Skip to main content
. 2017 Aug 17;1(19):1538–1545. doi: 10.1182/bloodadvances.2017007559

Table 1.

Baseline characteristics of patients treated with an ESA

Characteristic CKD MDS AUE Other etiology Total
No. % Mean SD No. % Mean SD No. % Mean SD No. % Mean SD No. % Mean SD
No. of patients* 13 46 19 23 101
Male sex 5 38 29 63 12 63 13 57 59 59
Age, y 78.8 8.4 76.7 7.6 72.6 9.5 73.3 9.8 75.4 8.7
Weight, kg 77.8 23.3 77.8 13.5 80.8 26.2 78.1 20.4 78.4 19.3
Comorbidity index 2.7 1.8 1.6 1.5 2.3 1.1 3.1 2.1 2.2 1.7
Hemoglobin, g/L 90.2 9.4 85.1 9.4 92.4 10.3 87.6 11.7 89.2 12.9
EPO, IU/L 31.4 50.4 147 145 86.4 178 68.1 99.2 103 140
eGFR, mL/min/1.73 m2 18.1 8.8 56.8 24.9 42.4 7.4 40.0 23.4 45.3 24.2
Other cytopenia 4 31 28 61 4 21 3 13 39 39

SD, standard deviation.

*

A total of 113 patients received ESAs, but 12 patients (2 of whom had AUE) did not have sufficient data to analyze the treatment response and are not included in this table.